# Efficacy and Safety of Fosaprepitant in Preventing Chemotherapy-induced Vomiting in Children Treated With Medium and High Emetic Chemotherapeutic Drugs

> **NCT05230654** · NA · UNKNOWN · sponsor: **Shanghai Children's Medical Center** · enrollment: 120 (estimated)

## Conditions studied

- Chemotherapy Induced Nausea and Vomiting Pediatric Cancer Patients

## Interventions

- **DRUG:** Fosaprepitant
- **DRUG:** Placebo(normal saline)

## Key facts

- **NCT ID:** NCT05230654
- **Lead sponsor:** Shanghai Children's Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-01
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-05-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05230654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05230654, "Efficacy and Safety of Fosaprepitant in Preventing Chemotherapy-induced Vomiting in Children Treated With Medium and High Emetic Chemotherapeutic Drugs". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05230654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*